Tenecteplase - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe AUST R: 75013Active ingredients:
Tenecteplase
Dosage form:
Injection, powder for
Sponsor:
Boehringer Ingelheim Pty Ltd
Phone:
02 8875 8800
|
From
10 Jul 2022
to
15 Oct 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in consumer demand
|
METALYSE tenecteplase (rch) 40mg powder for injection vial plus prefilled syringe AUST R: 75012Active ingredients:
Tenecteplase
Dosage form:
Injection, powder for
Sponsor:
Boehringer Ingelheim Pty Ltd
Phone:
02 8875 8800
|
Deletion from market:
02 Sep 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative strength is in limited availability.
A TGA web statement is available at www.tga.gov.au/safety/shortages/medicine-shortage-alerts/tenecteplase-metalyse-shortage-update
|